33 related articles for article (PubMed ID: 33325316)
1. Low plasma antioxidant status in patients with epilepsy and the role of antiepileptic drugs on oxidative stress.
Menon B; Ramalingam K; Kumar RV
Ann Indian Acad Neurol; 2014 Oct; 17(4):398-404. PubMed ID: 25506160
[TBL] [Abstract][Full Text] [Related]
2. Shedding light on the shadows: oxidative stress and its pivotal role in prostate cancer progression.
Biesiadecki M; Mołoń M; Balawender K; Kobylińska Z; Galiniak S
Front Oncol; 2024; 14():1393078. PubMed ID: 38774418
[TBL] [Abstract][Full Text] [Related]
3. The effect of SP/NK1R on expression and activity of glutaredoxin and thioredoxin proteins in prostate cancer cells.
Zarei Shandiz S; Assaran Darban R; Javid H; Ghahremanloo A; Hashemy SI
Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; ():. PubMed ID: 38334824
[TBL] [Abstract][Full Text] [Related]
4. Selenium in Prostate Cancer: Prevention, Progression, and Treatment.
Jiang J; Chen B; Tang B; Wei Q
Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765058
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis landscape in prostate cancer from molecular and metabolic perspective.
Liang J; Liao Y; Wang P; Yang K; Wang Y; Wang K; Zhong B; Zhou D; Cao Q; Li J; Zhao Y; Jiang N
Cell Death Discov; 2023 Apr; 9(1):128. PubMed ID: 37061523
[TBL] [Abstract][Full Text] [Related]
6. Impact of genetically predicted atrial fibrillation on cancer risks: A large cardio-oncology Mendelian randomization study using UK biobank.
Li W; Huang M; Wang R; Wang W
Front Cardiovasc Med; 2022; 9():974402. PubMed ID: 36684576
[TBL] [Abstract][Full Text] [Related]
7. Systematic review and meta-analysis of candidate gene association studies of benign prostate hyperplasia.
Lin L; Li P; Liu X; Xie X; Liu L; Singh AK; Singh HN
Syst Rev; 2022 Apr; 11(1):60. PubMed ID: 35382870
[TBL] [Abstract][Full Text] [Related]
8. Phloretin Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by Regulating the Inflammatory Response, Oxidative Stress and Apoptosis.
Hsu CY; Lin YS; Weng WC; Panny L; Chen HL; Tung MC; Ou YC; Lin CC; Yang CH
Life (Basel); 2021 Jul; 11(8):. PubMed ID: 34440487
[TBL] [Abstract][Full Text] [Related]
9. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
[TBL] [Abstract][Full Text] [Related]
10. Review of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancer.
Montie JE; Pienta KJ
Urology; 1994 Jun; 43(6):892-9. PubMed ID: 7515207
[TBL] [Abstract][Full Text] [Related]
11. Lower thiol, glutathione, and glutathione peroxidase levels in prostate cancer: a meta-analysis study.
Sajjaboontawee N; Supasitthumrong T; Tunvirachaisakul C; Nantachai K; Snabboon T; Reiche EMV; Simão ANC; Maes M
Aging Male; 2020 Dec; 23(5):1533-1544. PubMed ID: 33325316
[TBL] [Abstract][Full Text] [Related]
12. Thiol Groups as a Biomarker for the Diagnosis and Prognosis of Prostate Cancer.
Koike A; Robles BEF; da Silva Bonacini AG; de Alcantara CC; Reiche EMV; Dichi I; Maes M; Cecchini R; Simão ANC
Sci Rep; 2020 Jun; 10(1):9093. PubMed ID: 32499542
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress and body composition in prostate cancer and benign prostatic hyperplasia patients.
Cimino S; Favilla V; Russo GI; Galvano F; Li Volti G; Barbagallo I; Giofrè SV; D'Orazio N; DI Rosa A; Madonia M; Morgia G
Anticancer Res; 2014 Sep; 34(9):5051-6. PubMed ID: 25202090
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study.
Kaya E; Ozgok Y; Zor M; Eken A; Bedir S; Erdem O; Ebiloglu T; Ergin G
Adv Clin Exp Med; 2017 Oct; 26(7):1095-1099. PubMed ID: 29211357
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant defense system in prostate adenocarcinoma and benign prostate hyperplasia of elderly patients.
Szewczyk-Golec K; Tyloch J; Czuczejko J
Neoplasma; 2015; 62(1):119-23. PubMed ID: 25563375
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
